FibroScan | Digestive Health Associates of Texas | Dallas Texas
Search
Menu
  1. Physicians
    1. Adult Physicians
    2. Pediatric Physicians
    3. Advanced Practitioners
    4. Advanced Find
  2. Locations
  3. Services and Procedures
    1. Colonoscopy
    2. Upper GI Endoscopy
    3. Zenker Diverticulum
    4. High Resolution Anal Manometry
    5. High Resolution Esophageal Manometry
    6. Peroral Endoscopic Myotomy
    7. Wireless Capsule Motility Testing
    8. Transoral Incisionless Fundoplication
    9. FibroScan
  4. Research
    1. About Research Institute
    2. Clinical Trials
    3. Research Team
    4. Participate In A Clinical Trial Form
  5. About us
    1. History
    2. Leadership
    3. Pediatric
    4. Blog
    5. Newsroom
  6. Resources
    1. Forms
    2. Colonoscopy Prep
    3. Insurance
    4. Conditions
    5. Colon Cancer Awareness
  7. Careers
Search
The Consistent, Painless Approach to Liver Management

FibroScan

DHAT Research Institute, a division of Digestive Health Associates of Texas, P.A., now offers FibroScan®, an accurate, non-invasive, painless aid for managing patients with liver disease. FibroScan is FDA-approved for clinical management of patients with liver disease and is covered by most insurance carriers.

FibroScan 502 image

How does FibroScan work?

FibroScan works by emitting a pulse of energy, which you may feel as a slight vibration on your skin. FibroScan then measures the speed of this energy and immediately provides this information to your physician, who then uses it as part of a broader evaluation of your liver health.

The Benefits

  • Covered by most insurance plans and will accept self-pay
  • The procedure is painless and takes about 10 minutes
  • Consistent results
  • The examined area is 100x the size of a needle biopsy
  • No down time or missed work

For more information about FibroScan please contact:

DHAT Research Institute

972.265.8201 research@dhat.com

Patients with no insurance are not a problem. We accept cash payment as well. Call for Rates.

FibroScan Touch 502 logo

Indications Reference List

  • Abscess of liver
  • Acute and subacute hepatic failure
  • Acute and subacute hepatic failure with coma
  • Acute and subacute hepatic failure without coma
  • Acute delta-(super) infection of hepatitis B carrier
  • Acute hepatitis B with delta-agent with hepatic coma
  • Acute hepatitis B with delta-agent without hepatic coma
  • Acute hepatitis B without delta-agent and without hepatic coma
  • Acute hepatitis B without delta-agent with hepatic coma
  • Acute hepatitis C with hepatic coma
  • Acute hepatitis C without hepatic coma
  • Acute hepatitis E
  • Acute viral hepatitis, unspecified
  • Alcoholic cirrhosis of liver
  • Alcoholic cirrhosis of liver with ascites
  • Alcoholic cirrhosis of liver without ascites
  • Alcoholic fatty liver
  • Alcoholic fibrosis and sclerosis of liver
  • Alcoholic hepatic failure
  • Alcoholic hepatic failure with coma
  • Alcoholic hepatic failure without coma
  • Alcoholic hepatitis
  • Alcoholic hepatitis with ascites
  • Alcoholic hepatitis without ascites
  • Alcoholic liver disease, unspecified
  • Autoimmune hepatitis
  • Biliary cirrhosis, unspecified
  • Chronic active hepatitis, not elsewhere classified
  • Chronic hepatic failure
  • Chronic hepatic failure with coma
  • Chronic hepatic failure without coma
  • Chronic hepatitis, not elsewhere classified
  • Chronic hepatitis, unspecified
  • Chronic lobular hepatitis, not elsewhere classified
  • Chronic persistent hepatitis, not elsewhere classified
  • Chronic viral hepatitis B with delta-agent
  • Chronic viral hepatitis B without delta-agent
  • Chronic viral hepatitis C
  • Chronic viral hepatitis, unspecified
  • Cytomegaloviral hepatitis
  • Fatty (change of) liver, not elsewhere classified
  • Fibrosis and cirrhosis of liver
  • Granulomatous hepatitis, not elsewhere classified
  • Hepatic failure, not elsewhere classified
  • Hepatic failure, unspecified
  • Hepatic failure, unspecified with coma
  • Hepatic fibrosis
  • Hepatic fibrosis with hepatic sclerosis
  • Hepatic sclerosis
  • Hepatitis A with hepatic coma
  • Hepatitis A without hepatic coma
  • Heptatic failure, unspecified without coma
  • Herpes viral hepatitis
  • Inflammatory liver disease, unspecified
  • Liver disease, unspecified
  • Liver disorders in diseases classified elsewhere
  • Mumps hepatitis
  • Nonalcoholic steatohepatitis (NASH)
  • Nonspecific reactive hepatitis
  • Other and unspecified cirrhosis of liver
  • Other chronic hepatitis, not elsewhere classified
  • Other chronic viral hepatitis
  • Other cirrhosis of liver
  • Other diseases of liver
  • Other inflammatory liver diseases
  • Other specified acute viral hepatitis
  • Other specified diseases of liver
  • Other specified inflammatory liver diseases
  • Primary biliary cirrhosis
  • Secondary biliary cirrhosis
  • Secondary syphilitic hepatitis
  • Sequela of viral hepatitis
  • Toxic liver disease
  • Toxic liver disease with acute hepatitis
  • Toxic liver disease with cholestasis
  • Toxic liver disease with chronic active hepatitis
  • Toxic liver disease with chronic active hepatitis with ascites
  • Toxic liver disease with chronic active hepatitis without ascites
  • Toxic liver disease with chronic lobular hepatitis
  • Toxic liver disease with chronic persistent hepatitis
  • Toxic liver disease with fibrosis and cirrhosis of liver
  • Toxic liver disease with hepatic necrosis, without coma
  • Toxic liver disease with hepatitis, not elsewhere classified
  • Toxic liver disease with other disorders of liver
  • Toxic liver disease, unspecified
  • Toxoplasma hepatitis
  • Unspecified cirrhosis of liver
  • Unspecified viral hepatitis B with hepatic coma
  • Unspecified viral hepatitis B without hepatic coma
  • Unspecified viral hepatitis C with hepatic coma
  • Unspecified viral hepatitis C without hepatic coma
  • Unspecified viral hepatitis with hepatic coma
  • Unspecified viral hepatitis without hepatic coma
DHAT
Copyright 2020 by DHAT - Digestive Health Association of Texas. Terms Of Use |  Privacy Statement
Back To Top